Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Antoniucci

Showing results (121-130 of 203) with videos related to

Pageof 21
Sort By:
JACC. Cardiovascular Interventions|September 21, 2015
Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis)Renato Valenti, Rossella Marcucci, Vincenzo Comito, et al.
American Heart Journal|June 4, 2014
Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 studyGuido Parodi, Benedetta Bellandi, Renato Valenti, et al.
European Heart Journal|January 26, 2007
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-upGilles Montalescot, David Antoniucci, Adnan Kastrati, et al.
Thrombosis and Haemostasis|May 29, 2010
High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stentingRossella Marcucci, Anna Maria Gori, Rita Paniccia, et al.
Circulation|January 2, 2009
Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-upRossella Marcucci, Anna Maria Gori, Rita Paniccia, et al.
The American Journal of Cardiology|March 10, 2009
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosisBetti Giusti, Anna Maria Gori, Rossella Marcucci, et al.
Thrombosis and Haemostasis|January 10, 2009
Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet functionAnna Maria Gori, Rossella Marcucci, Rita Paniccia, et al.
Journal of the American College of Cardiology|June 19, 2007
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosisPiergiovanni Buonamici, Rossella Marcucci, Angela Migliorini, et al.
JAMA|September 22, 2011
High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCIGuido Parodi, Rossella Marcucci, Renato Valenti, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 18, 2010
Prevalence and clinical significance of acquired left coronary artery fistulas after surgical myectomy in patients with hypertrophic cardiomyopathyAurelio Sgalambro, Iacopo Olivotto, Alessandra Rossi, et al.
Pageof 21

Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
JACC. Cardiovascular Interventions|September 21, 2015
Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis)Renato Valenti, Rossella Marcucci, Vincenzo Comito, et al.
American Heart Journal|June 4, 2014
Comparison of double (360 mg) ticagrelor loading dose with standard (60 mg) prasugrel loading dose in ST-elevation myocardial infarction patients: the Rapid Activity of Platelet Inhibitor Drugs (RAPID) primary PCI 2 studyGuido Parodi, Benedetta Bellandi, Renato Valenti, et al.
European Heart Journal|January 26, 2007
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-upGilles Montalescot, David Antoniucci, Adnan Kastrati, et al.
Thrombosis and Haemostasis|May 29, 2010
High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stentingRossella Marcucci, Anna Maria Gori, Rita Paniccia, et al.
Circulation|January 2, 2009
Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-upRossella Marcucci, Anna Maria Gori, Rita Paniccia, et al.
The American Journal of Cardiology|March 10, 2009
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosisBetti Giusti, Anna Maria Gori, Rossella Marcucci, et al.
Thrombosis and Haemostasis|January 10, 2009
Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet functionAnna Maria Gori, Rossella Marcucci, Rita Paniccia, et al.
Journal of the American College of Cardiology|June 19, 2007
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosisPiergiovanni Buonamici, Rossella Marcucci, Angela Migliorini, et al.
JAMA|September 22, 2011
High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCIGuido Parodi, Rossella Marcucci, Renato Valenti, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 18, 2010
Prevalence and clinical significance of acquired left coronary artery fistulas after surgical myectomy in patients with hypertrophic cardiomyopathyAurelio Sgalambro, Iacopo Olivotto, Alessandra Rossi, et al.
Pageof 21